Parsons Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $779K | Buy |
10,853
+5,027
| +86% | +$387K | 0.04% | 306 |
|
|
2025
Q4 | $462K | Buy |
+5,826
| New | +$459K | 0.03% | 332 |
|
|
2024
Q4 | – | Sell |
-32,479
| Closed | -$2.04M | – | 444 |
|
|
2024
Q3 | $2.04M | Sell |
32,479
-861
| -3% | -$50.2K | 0.13% | 158 |
|
|
2024
Q2 | $1.97M | Sell |
33,340
-191
| -0.6% | -$11.9K | 0.13% | 155 |
|
|
2024
Q1 | $2.67M | Sell |
33,531
-14,945
| -31% | -$1.14M | 0.18% | 125 |
|
|
2023
Q4 | $3.83M | Sell |
48,476
-2,291
| -5% | -$163K | 0.27% | 89 |
|
|
2023
Q3 | $3.54M | Sell |
50,767
-2,217
| -4% | -$157K | 0.28% | 85 |
|
|
2023
Q2 | $3.66M | Sell |
52,984
-3,763
| -7% | -$268K | 0.28% | 82 |
|
|
2023
Q1 | $4.22M | Buy |
56,747
+662
| +1% | +$55.5K | 0.34% | 69 |
|
|
2022
Q4 | $5.23M | Buy |
56,085
+3,388
| +6% | +$327K | 0.44% | 52 |
|
|
2022
Q3 | $5.03M | Buy |
52,697
+267
| +0.5% | +$26.4K | 0.45% | 48 |
|
|
2022
Q2 | $4.86M | Sell |
52,430
-555
| -1% | -$54.2K | 0.44% | 52 |
|
|
2022
Q1 | $5.36M | Buy |
52,985
+352
| +0.7% | +$37K | 0.41% | 53 |
|
|
2021
Q4 | $5.43M | Buy |
52,633
+138
| +0.3% | +$12.8K | 0.39% | 56 |
|
|
2021
Q3 | $4.46M | Buy |
52,495
+2,239
| +4% | +$188K | 0.35% | 69 |
|
|
2021
Q2 | $4.19M | Buy |
50,256
+12,785
| +34% | +$1.05M | 0.32% | 74 |
|
|
2021
Q1 | $2.82M | Buy |
37,471
+196
| +0.5% | +$14.3K | 0.23% | 97 |
|
|
2020
Q4 | $2.54M | Buy |
37,275
+3,837
| +11% | +$250K | 0.22% | 100 |
|
|
2020
Q3 | $1.95M | Buy |
33,438
+920
| +3% | +$57.2K | 0.19% | 108 |
|
|
2020
Q2 | $2.11M | Buy |
32,518
+2,084
| +7% | +$131K | 0.23% | 96 |
|
|
2020
Q1 | $1.81M | Buy |
30,434
+202
| +0.7% | +$13.5K | 0.23% | 97 |
|
|
2019
Q4 | $2.25M | Sell |
30,232
-69
| -0.2% | -$4.84K | 0.23% | 108 |
|
|
2019
Q3 | $1.91M | Sell |
30,301
-1,340
| -4% | -$79.4K | 0.21% | 113 |
|
|
2019
Q2 | $1.72M | Sell |
31,641
-1,333
| -4% | -$71.8K | 0.19% | 122 |
|
|
2019
Q1 | $1.78M | Sell |
32,974
-40,483
| -55% | -$2.5M | 0.19% | 119 |
|
|
2018
Q4 | $4.81M | Buy |
73,457
+373
| +0.5% | +$27.8K | 0.59% | 37 |
|
|
2018
Q3 | $5.75M | Sell |
73,084
-1,151
| -2% | -$82.3K | 0.61% | 34 |
|
|
2018
Q2 | $4.78M | Buy |
74,235
+449
| +0.6% | +$29.6K | 0.54% | 41 |
|
|
2018
Q1 | $4.59M | Sell |
73,786
-407
| -0.5% | -$29.2K | 0.53% | 42 |
|
|
2017
Q4 | $5.38M | Sell |
74,193
-2,624
| -3% | -$191K | 0.6% | 34 |
|
|
2017
Q3 | $6.25M | Sell |
76,817
-2,460
| -3% | -$195K | 0.74% | 30 |
|
|
2017
Q2 | $6.38M | Buy |
79,277
+522
| +0.7% | +$41.2K | 0.78% | 27 |
|
|
2017
Q1 | $6.18M | Buy |
78,755
+3,035
| +4% | +$242K | 0.78% | 28 |
|
|
2016
Q4 | $5.97M | Sell |
75,720
-8,326
| -10% | -$674K | 0.79% | 29 |
|
|
2016
Q3 | $7.48M | Sell |
84,046
-630
| -0.7% | -$59.5K | 1.01% | 16 |
|
|
2016
Q2 | $8.11M | Sell |
84,676
-20
| -0% | -$1.99K | 1.1% | 15 |
|
|
2016
Q1 | $8.79M | Buy |
84,696
+3,013
| +4% | +$293K | 1.2% | 12 |
|
|
2015
Q4 | $7.99M | Buy |
81,683
+3,341
| +4% | +$327K | 1.12% | 13 |
|
|
2015
Q3 | $7.56M | Buy |
78,342
+4,597
| +6% | +$483K | 1.1% | 13 |
|
|
2015
Q2 | $7.73M | Sell |
73,745
-230
| -0.3% | -$23.5K | 1.03% | 14 |
|
|
2015
Q1 | $7.63M | Sell |
73,975
-2,482
| -3% | -$251K | 1.07% | 11 |
|
|
2014
Q4 | $7.36M | Buy |
76,457
+1,060
| +1% | +$93.4K | 0.98% | 16 |
|
|
2014
Q3 | $6M | Sell |
75,397
-1,449
| -2% | -$114K | 0.83% | 24 |
|
|
2014
Q2 | $5.79M | Sell |
76,846
-5,725
| -7% | -$433K | 0.79% | 25 |
|
|
2014
Q1 | $6.18M | Sell |
82,571
-4,610
| -5% | -$326K | 0.88% | 18 |
|
|
2013
Q4 | $6.24M | Sell |
87,181
-2,108
| -2% | -$135K | 0.94% | 18 |
|
|
2013
Q3 | $5.07M | Sell |
89,289
-1,910
| -2% | -$114K | 0.83% | 24 |
|
|
2013
Q2 | $5.21M | Buy |
+91,199
| New | +$5.28M | 0.9% | 21 |
|
Other funds holding CVS
VCM
VPM
Parsons Capital Management's CVS Position: Q1 2026 in Review
Parsons Capital Management increased its CVS Health (CVS) stake by 86% in Q1 2026, buying an estimated $387K and bringing the position to 10,853 shares worth $779K. The position accounts for 0.04% of the portfolio, ranked #306.
Parsons Capital Management first reported a position in CVS in Q2 2013 and has held it in 48 quarters since. The position peaked at $8.79M in Q1 2016. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Parsons Capital Management held 10,853 shares of CVS Health worth $779K as of Q1 2026.
- Parsons Capital Management bought 5,027 CVS Health shares in Q1 2026, an estimated $387K.
- CVS Health made up 0.04% of Parsons Capital Management's portfolio in Q1 2026, its #306 holding.
- Parsons Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 48 quarters since.
- Parsons Capital Management's CVS Health position peaked at $8.79M in Q1 2016.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Parsons Capital Management's 13F filing for Q1 2026, filed 15 Apr 2026.